Executives On The Move: C4 Therapeutics Appoints A CMO, Innovio Pharma Brings In A COO, And A Departure At The Top For Sandoz
Executive Summary
Targeted protein degradation company C4 Therapeutics welcomes former Novartis development leader as its CMO and immunotherapy technology firm Innovio hires a COO. At Sandoz, the chief executive departs.